CLINICAL_TRIALS
trial_result
· 2019-03-21
Clinical Trial Update: Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II) [Phase 2]
Summary
Phase 2 long-term follow-up study updates safety and tolerability of atacicept in systemic lupus erythematosus (SLE) after participation in ADDRESS II; study te…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMD Serono | Conditions: Lupus Erythematosus, Systemic | Phase 2 | Status: TERMINATED | Results posted: 2019-03-21